Okairos' Acquisition

Okairos was acquired by GlaxoSmithKline on May 29, 2013.

Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, HIV, respiratory syncytial virus and cancer - using a…

Articles about Okairos' Acquisition: